No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cassava Sciences Shifts Focus to TSC-Related Epilepsy
10-Q: Q1 2025 Earnings Report
Cassava Sciences Q1 EPS $(0.48) Down From $(0.43) YoY
Express News | Cassava Sciences Inc - Reduces Workforce by 33% in Q1 2025
Express News | Cassava Reports Q1 2025 Financials Results, Provides Business Update
Press Release: Cassava Reports Q1 2025 Financials Results, Provides Business Update